Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 18/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.47 |
| ▸ | CTSD | P07339 | 3/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30476106 | 0.98 | BACE1 (0.49) | BACE1BACE2CTSD | |
| SCHEMBL31453841 | 0.92 | DPP4 (0.39) | BACE1BACE2CTSD | |
| SCHEMBL30640025 | 0.92 | BACE1 (0.48) | BACE1BACE2CTSD | |
| SCHEMBL29370926 | 0.91 | BACE1 (0.42) | BACE1BACE2CTSD | |
| SCHEMBL17768459 | 0.90 | DPP4 (0.40) | BACE1BACE2CTSD | |
| SCHEMBL2780879 | 0.90 | DPP4 (0.40) | BACE1BACE2CTSD | |
| SCHEMBL29530854 | 0.89 | ERAP2 (0.47) | BACE1BACE2CTSD | |
| SCHEMBL29530852 | 0.89 | ERAP2 (0.47) | BACE1BACE2CTSD | |
| SCHEMBL29842532 | 0.89 | NAALAD2 (0.38) | BACE1BACE2 | |
| SCHEMBL31130605 | 0.88 | ERAP2 (0.48) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727937-A1 | CRYSTALLINE PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORM OF THE GLUTAMINYL CYCLASE INHIBITOR VAROGLUTAMSTAT | Vivoryon Therapeutics N.V. (DE) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024256618-A1 | CRYSTALLINE PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORM OF THE GLUTAMINYL CYCLASE INHIBITOR VAROGLUTAMSTAT | VIVORYON THERAPEUTICS N.V. (DE) | 2024-12-19 | — | — | WO | disclosed |